AXT (AXTI) rises 9.1% after expanding stock authorization to support AI capacity expansion – Has the bull market changed?

• At its 2026 Annual Meeting on June 4, AXT, Inc. received shareholder approval for an amendment to its Amended Articles of Incorporation increasing the number of authorized common shares from 70,000,000 to 102,000,000 to support its ongoing capital needs.
• This governance change comes on the heels of AXT raising US$632.5 million for capacity expansion in indium phosphide substrates to meet AI and optical data center demands, directly linking balance sheet flexibility to growth investment plans.
• Here, we consider how expanding equity authorizations associated with AI-focused capacity expansion could reshape AXT’s existing investment story.

This technology has the potential to replace computers. Discover 29 stocks that are making quantum computing a reality.

AXT Investment Narrative Summary

To become an AXT shareholder today, you need to believe that the growing demand for AI and optical data centers will lead to increased revenue and, ultimately, higher margins, despite export permit uncertainties and significant exposure to China. The recent approval to increase authorized shares primarily increases short-term funding flexibility for AI-focused capacity building, but does not significantly change immediate execution risks regarding export licenses and concentrated customers.

The most relevant recent move is AXT’s US$632.5 million capital raise to expand its indium phosphide production capacity through 2027. The latest funding, backed by a larger equity grant, is central to the bullish catalyst for AXT to capture more AI-related optical demand, but it still faces short-term tensions between rapid capacity growth and current thin margins and share dilution.

But behind the AI ​​growth story, investors should also be aware that fluctuations in export permits and customer concentration may still persist…

Read the full story on AXT (it’s free!)

The AXT story projects revenue of $238.5 million and revenue of $62.6 million by 2029. This would require a 39.3% increase in annual revenue, with revenues increasing by approximately $84 million from the current -$21.4 million.

We reveal how AXT’s forecast yields a fair value of $30.75, which is 68% lower than its current price.

explore other perspectives

Some of the lowest analyst forecasts paint a much more cautious outlook, assuming sales of around US$380.6m and profits of US$189.5m by 2029, a reminder that expectations and risks regarding Axient’s stock approvals and export restrictions can be viewed very differently.

Check out 5 other fair value estimates on AXT – Find out why the stock is worth more than twice its current price.

The verdict is yours

Don’t agree with the existing narrative? Following the herd rarely yields exceptional investment returns. Follow your intuition.

Looking for a fresh perspective?

Don’t miss your chance to be the next 10 bagger. Latest stocks fell:

This article by Simply Wall St is general in nature. We provide commentary using only unbiased methodologies, based on historical data and analyst forecasts, and articles are not intended to be financial advice. This is not a recommendation to buy or sell any stock, and does not take into account your objectives or financial situation. We aim to provide long-term, focused analysis based on fundamental data. Note that our analysis may not factor in the latest announcements or qualitative material from price-sensitive companies. Simply Wall St has no position in any stocks mentioned.

Do you have feedback about this article? Interested in its content? Please contact us directly. Alternatively, email editorial-team@simplywallst.com.